Brawn Biotech Ltd
Know More24.40↑1.05 (4.50%)
12:00 AM,8th Dec 2023BSE : 530207
NSE :
Sector : Others
ISIN Code : INE899B01015
- NSE
- BSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: Dec 08 2023 | 12:00 AM IST
| Market Cap (₹ Cr) | 0 |
Turnover (₹ Cr) | 0.00 |
Volume (Shares) | |
Face Value | 10 |
52-WK High | 0.00 |
52-WK High Date | Invalid date |
52-WK Low | 0.00 |
52-WK Low Date | Invalid date |
All Time High | 0.00 |
All Time High Date | Invalid date |
All Time Low | 0.00 |
All Time Low Date | Invalid date |
Brawn Biotech Ltd
BRAWN with its inception barely 26 years back (1985) has today evolved into a fully integrated healthcare group marking its presence in India and dotting various major markets across the globe. BRAWN is proud to possess product registration with major health and govt. institutions throughout India and in many other countries worldwide. Headed and represented by a team of skilled industry experts with impressive educational backgrounds and broad experience BRAWN continues to spread its wings in expansion in the domestic as well as in the international markets with a vision beyond the existing horizon to stand among the leading Indian HealthCare products distribution Companies.Their Pharmaceutical Products cover all major product segments like Antibacterials Cardiovasculars Antidiabetics Analgesics Gastrointestinals Antifungals Skin Care Antipsychotics Antiasthmatics Antacids Antimalarials and Nutritionals.Besides a professional and competent team that looks into administration sales marketing maintenance etc. Brawn is supported by a team of highly qualified and experienced consultants to gain an edge over the others in the market.
News
View MoreAnnouncement
View MoreBrawn Biotech Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 7 |
| EPS - TTM (₹) [S] | 0.00 |
| P/E Ratio (X) [S] | 1.28 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 10.00 |
| Latest Dividend Date | 12 Sep 2018 |
| Dividend Yield (%) | - |
| Book Value Share (₹) [S] | 19.03 |
| P/B Ratio (₹) [S] | 1.28 |
| [*C] Consolidated [*S] Standalone | |
Funds Owing this Stock
| Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
|---|
Research Reports
| Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
|---|---|---|---|---|
| Data Not Found |
Stock Strength
| Today's Low/High | 23.35 24.50 |
| Week Low/High | 19.38 25.00 |
| Month Low/High | 16.00 25.00 |
| Year Low/High | 14.36 25.00 |
| All time Low/High | 0.40 96.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 25.64% | % | 3.47 | 3.46% |
| 1 Month | 38.87% | % | 7.46 | 7.85% |
| 3 Month | % | % | 4.84 | 5.80% |
| 6 Month | 53.65% | % | 11.10 | 12.53% |
| 1 Year | % | % | 11.59 | 12.68% |
| 3 Year | 6.55% | % | 53.10 | 56.57% |
Company Info
Company Information
Director : Brij Bala Gupta.
Independent Director : Kanta Takkar
Independent Director : Subhash Chander
Company Sec. & Compli. Officer : Priyanka Sharma
Registered Office: C-64 Lajpat Nagar-1 1st Floor, ,New Delhi,New Delhi-110024 Ph:
Email:solution@brawnpharma.com
